Patient characteristics at study entry
| Characteristic . | Patient cohort . | |
|---|---|---|
| IM-only (n = 19) . | IFN-IM (n = 21) . | |
| Median age (y) | 58 | 62 |
| Males (%) | 37 | 57 |
| Sokal score | ||
| High | 3 | 1 |
| Intermediate | 8 | 8 |
| Low | 8 | 12 |
| Median duration of IM (mo) | 70 | 72 |
| Median cumulative IM dose (g) | 947 | 914 |
| Median duration of stable UMRD (mo) | 30 | 41 |
| Characteristic . | Patient cohort . | |
|---|---|---|
| IM-only (n = 19) . | IFN-IM (n = 21) . | |
| Median age (y) | 58 | 62 |
| Males (%) | 37 | 57 |
| Sokal score | ||
| High | 3 | 1 |
| Intermediate | 8 | 8 |
| Low | 8 | 12 |
| Median duration of IM (mo) | 70 | 72 |
| Median cumulative IM dose (g) | 947 | 914 |
| Median duration of stable UMRD (mo) | 30 | 41 |
All comparisons between cohorts P > .05.